TrialThe pharmacogenomics journal2014

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.

F V Negri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.